Podcast: BioVectra Is An Emerging Force In Pharmaceutical Manufacturing in Canada
BioVectra plans to build a facility on Prince Edward Island that will eventually manufacture enough doses of mRNA vaccines to supply all of Canada, which is big news for Canadians as well as Atlantic Canadians. The recent announcement shines a light on a 50-year old company that employs more than 550 people in P.E.I. and Nova Scotia.
“There are 35 million-plus Canadians. We could probably within a year single-handedly make sure the demand for Canada has been taken care of if we were the ones to produce the vaccine in the future,” says company CEO Oliver Technow.
On this episode of the “Insights” podcast, Technow speaks with co-host Don Mills about the origins of the company and the original vision of its founder Regis Duffy, and how the company has grown over the decades to its present capabilities.
Technow talks about the number of new employees that will be added as a result of the announcement and the challenges of recruiting talent for these high-paying skilled jobs in the Atlantic region.
You can listen to their conversation in the player above or search for “Huddle Insights” on a podcast platform like Apple or Spotify. Follow the show and never miss an episode. You can also listen to past episodes on those platforms.
The “Insights” podcast combines the experiences of an economist, David Campbell, and a social scientist, Don Mills, to explore the challenges and opportunities facing Atlantic Canada, to promote data-driven decision-making among policymakers, and to encourage a wider dialogue and debate leading to greater prosperity for the region.